|
hepatocellular carcinoma |
42 |
|
extracellular vesicles |
22 |
|
humans |
17 |
|
nidogen 1 |
15 |
|
animals |
14 |
|
neutralizing antibody |
14 |
|
cell line, tumor |
13 |
|
intercellular communication |
13 |
|
mice |
13 |
|
small extracellular vesicles |
12 |
|
tumor microenvironment |
12 |
|
pre‐metastatic niche |
11 |
|
proteomics |
11 |
|
tumor necrosis factor receptor 1 |
11 |
|
cell movement |
10 |
|
cell proliferation |
10 |
|
gene expression regulation, neoplastic |
10 |
|
liver cancer |
10 |
|
tumor suppressor proteins - genetics - metabolism |
10 |
|
adult |
9 |
|
aged |
9 |
|
biomarkers |
9 |
|
cancer metastasis |
9 |
|
female |
9 |
|
male |
9 |
|
middle aged |
9 |
|
therapeutics |
9 |
|
young adult |
9 |
|
galectin-1 |
8 |
|
glycolysis |
8 |
|
mice, nude |
8 |
|
mir-22 |
8 |
|
molecular sequence data |
8 |
|
otx008 |
8 |
|
rab20 gtpase |
8 |
|
triosephosphate isomerase 1 |
8 |
|
tumourigenesis |
8 |
|
adolescent |
7 |
|
beta catenin - metabolism |
7 |
|
carcinoma, hepatocellular - genetics - mortality - secondary |
7 |
|
caveolin 1 - genetics - metabolism |
7 |
|
caveolin-1 |
7 |
|
cell line |
7 |
|
clone cells |
7 |
|
disease models, animal |
7 |
|
disease progression |
7 |
|
epigenesis, genetic |
7 |
|
gene knockdown techniques |
7 |
|
gene silencing |
7 |
|
hong kong - epidemiology |
7 |
|
liver - metabolism - pathology |
7 |
|
liver neoplasms - genetics - mortality - pathology |
7 |
|
metastasis |
7 |
|
mice, inbred balb c |
7 |
|
neoplasm transplantation |
7 |
|
phosphoproteins - genetics - metabolism |
7 |
|
survival rate |
7 |
|
up-regulation |
7 |
|
wnt proteins - metabolism |
7 |
|
carcinoma, hepatocellular - metabolism |
6 |
|
cardiac myosins - metabolism |
6 |
|
clathrin light chain a |
6 |
|
feedback signaling |
6 |
|
gtpase-activating proteins - genetics - metabolism |
6 |
|
high-grade tumor |
6 |
|
liver neoplasms - metabolism |
6 |
|
myosin light chains - metabolism |
6 |
|
nf-κb signaling |
6 |
|
nuclear factor kappa b |
6 |
|
nuclear met |
6 |
|
ovarian cancer |
6 |
|
prognosis |
6 |
|
rna, messenger - metabolism |
6 |
|
tak1 |
6 |
|
transcription, genetic |
6 |
|
transforming growth factor beta-activated kinase 1 |
6 |
|
von willebrand factor |
6 |
|
3t3 cells |
5 |
|
acquired chemoresistance |
5 |
|
actins - metabolism |
5 |
|
aged, 80 and over |
5 |
|
amino acid sequence |
5 |
|
biomarker |
5 |
|
carcinoma, hepatocellular - enzymology - genetics - pathology |
5 |
|
carcinoma, hepatocellular - genetics - metabolism |
5 |
|
carcinoma, hepatocellular - genetics - metabolism - pathology |
5 |
|
cell adhesion - physiology |
5 |
|
cell shape |
5 |
|
cell transformation, neoplastic |
5 |
|
cell transformation, neoplastic - genetics - metabolism |
5 |
|
chemoresistance |
5 |
|
deleted in liver cancer 1 |
5 |
|
deleted in liver cancer 2 |
5 |
|
enzyme activation |
5 |
|
epithelial ovarian cancer |
5 |
|
fibroblasts - cytology - physiology |
5 |
|
gene expression regulation, neoplastic - genetics |
5 |
|
genes, tumor suppressor |
5 |
|
growth suppressor protein |
5 |
|
grp78 |
5 |
|
gtpase-activating proteins |
5 |
|
hypoxia |
5 |
|
isoforms |
5 |
|
jag1-notch1 |
5 |
|
lipid droplets |
5 |
|
liver - metabolism |
5 |
|
liver neoplasms - enzymology - genetics - pathology |
5 |
|
liver neoplasms - genetics - metabolism |
5 |
|
liver neoplasms - genetics - metabolism - pathology |
5 |
|
microrna |
5 |
|
mir-199b-5p |
5 |
|
mitochondria |
5 |
|
mitochondria, liver - genetics - metabolism |
5 |
|
molecular mechanisms |
5 |
|
molecular oncology |
5 |
|
oxygenation |
5 |
|
oxylab po2 |
5 |
|
phosphatidylinositol 3-kinases - metabolism |
5 |
|
protein isoforms |
5 |
|
protein isoforms - genetics - metabolism |
5 |
|
protein stability |
5 |
|
protein structure, tertiary - genetics |
5 |
|
protein transport - genetics |
5 |
|
ras proteins - metabolism |
5 |
|
recombinant fusion proteins - genetics - metabolism |
5 |
|
rhoa gtp-binding protein - antagonists & inhibitors - metabolism |
5 |
|
signaling pathways |
5 |
|
steroidogenic acute regulatory protein-related lipid transfer domain |
5 |
|
tumor stem cell assay |
5 |
|
upr pathway |
5 |
|
adaptor proteins, signal transducing - genetics - metabolism |
4 |
|
cancers |
4 |
|
capping actin protein gelsolin-like |
4 |
|
carcinoma, hepatocellular - metabolism - pathology - physiopathology |
4 |
|
cell division - physiology |
4 |
|
cell growth suppression |
4 |
|
complement factor h |
4 |
|
complement-mediated cytotoxicity |
4 |
|
consensus sequence |
4 |
|
differentiation |
4 |
|
dlc2 (deleted in liver cancer 2) |
4 |
|
drug deliveries |
4 |
|
endocytosis |
4 |
|
hepatocellularcarcinoma |
4 |
|
hypoxia-inducible factor-1 |
4 |
|
integrins |
4 |
|
kidney - cytology |
4 |
|
lim domain proteins |
4 |
|
liver neoplasms - metabolism - pathology - physiopathology |
4 |
|
lung metastases |
4 |
|
mutation - genetics |
4 |
|
neuroblastoma |
4 |
|
patient-derived xenografts |
4 |
|
pitstop 2 |
4 |
|
premetastatic niche |
4 |
|
raf-1-erk1/2-p70s6k signalling |
4 |
|
regression |
4 |
|
signal transduction |
4 |
|
signal transduction - physiology |
4 |
|
treatment |
4 |
|
ubiquitin - metabolism |
4 |
|
vascular permeability |
4 |
|
akt |
3 |
|
antibody specificity |
3 |
|
arp2/3 |
3 |
|
arpc2 |
3 |
|
binding sites |
3 |
|
biogenesis |
3 |
|
carcinoma, hepatocellular - genetics - physiopathology |
3 |
|
carcinoma, hepatocellular - pathology |
3 |
|
carrier proteins - chemistry - genetics - metabolism |
3 |
|
caveolae - pathology - physiology |
3 |
|
cell cycle |
3 |
|
cell cycle - physiology |
3 |
|
cell motility |
3 |
|
cell movement - physiology |
3 |
|
cell nucleus - drug effects - metabolism |
3 |
|
cell nucleus - metabolism |
3 |
|
cells, cultured |
3 |
|
chromosome aberrations |
3 |
|
colony-forming units assay |
3 |
|
crispr/cas9 |
3 |
|
cytoplasm - metabolism |
3 |
|
dna-binding proteins - genetics - metabolism |
3 |
|
endocytosis - physiology |
3 |
|
endophilin |
3 |
|
epigenetics |
3 |
|
extra eleven nineteen (een) |
3 |
|
fatty acids, unsaturated - pharmacology |
3 |
|
genes, reporter |
3 |
|
genetic alterations |
3 |
|
glutathione transferase - metabolism |
3 |
|
gtpase-activating proteins - metabolism |
3 |
|
intracellular signaling peptides and proteins |
3 |
|
intracellular signaling peptides and proteins - metabolism |
3 |
|
kidney |
3 |
|
knockout |
3 |
|
leukaemia |
3 |
|
leukemia - metabolism |
3 |
|
liver - physiology |
3 |
|
liver neoplasms - genetics - physiopathology |
3 |
|
liver neoplasms - metabolism - pathology |
3 |
|
medical sciences |
3 |
|
mice, knockout |
3 |
|
microfilament proteins - genetics - metabolism |
3 |
|
mitosis |
3 |
|
mitosis - physiology |
3 |
|
molecular pathogenesis |
3 |
|
mutagenesis, site-directed |
3 |
|
neoplasm invasiveness |
3 |
|
nucleocytoplasmic shuttling |
3 |
|
nucleocytoplasmic transport proteins |
3 |
|
oncology |
3 |
|
p-glycoproteins - genetics |
3 |
|
phosphoprotein phosphatases - metabolism |
3 |
|
phosphoric monoester hydrolases - genetics - metabolism |
3 |
|
phosphorylation |
3 |
|
polymorphism, single nucleotide |
3 |
|
protein transport |
3 |
|
protein-serine-threonine kinases - metabolism |
3 |
|
proteins - immunology - metabolism - physiology |
3 |
|
proto-oncogene proteins c-akt - metabolism |
3 |
|
proto-oncogenes |
3 |
|
sequence deletion |
3 |
|
signal transduction - genetics - physiology |
3 |
|
src homology domains |
3 |
|
steroid isomerases |
3 |
|
subcellular fractions - metabolism |
3 |
|
tor serine-threonine kinases |
3 |
|
transfection |
3 |
|
tumor markers, biological - genetics - metabolism |
3 |
|
tumor oncology |
3 |
|
wnt signaling |
3 |
|
a-549 cell line |
2 |
|
anoikis - drug effects - physiology |
2 |
|
antineoplastic agents - pharmacology |
2 |
|
bacterial extracellular vesicles |
2 |
|
base sequence |
2 |
|
blotting, western |
2 |
|
calcium/calmodulin-dependent protein kinase 2 isoform a |
2 |
|
cancer immunotherapy |
2 |
|
cancer inhibition |
2 |
|
cancer stem cell |
2 |
|
cancer stem cells |
2 |
|
cancer survival |
2 |
|
cancer therapy |
2 |
|
cancer treatment |
2 |
|
carcinoma, hepatocellular - metabolism - pathology |
2 |
|
cell renewal |
2 |
|
cell transformation, neoplastic - metabolism |
2 |
|
cisplatin - pharmacology |
2 |
|
clinicopathological significance |
2 |
|
cloning, molecular |
2 |
|
complement |
2 |
|
controlled study |
2 |
|
cysteine rich domain |
2 |
|
dc vaccines |
2 |
|
dendritic cells |
2 |
|
diagnosis |
2 |
|
drug resistance, neoplasm - physiology |
2 |
|
enzyme activation - drug effects - physiology |
2 |
|
enzyme phosphorylation |
2 |
|
exosome |
2 |
|
focal adhesion proteins |
2 |
|
focal adhesions - enzymology - metabolism |
2 |
|
frizzled related protein |
2 |
|
gene expression regulation |
2 |
|
glutathione s-transferase pi |
2 |
|
gtpase-activating proteins - chemistry - genetics - metabolism |
2 |
|
hepatocyte growth factor - metabolism |
2 |
|
hydrophobic and hydrophilic interactions |
2 |
|
in situ nick-end labeling |
2 |
|
integrin linked kinase |
2 |
|
inter-kingdom communication |
2 |
|
liquid biopsy |
2 |
|
liver carcinogenesis |
2 |
|
lung adenocarcinoma |
2 |
|
macropinocytosis |
2 |
|
microfilament proteins - chemistry - genetics - metabolism |
2 |
|
mitogen-activated protein kinase 1 - metabolism |
2 |
|
mitogen-activated protein kinase 3 - metabolism |
2 |
|
mutant p53 |
2 |
|
mutation |
2 |
|
neoplasm proteins - metabolism |
2 |
|
netrin-like domain |
2 |
|
nuclear factor erythroid 2-related factor 2 |
2 |
|
ovarian neoplasms - metabolism |
2 |
|
ovary |
2 |
|
paclitaxel - pharmacology |
2 |
|
ph regulation |
2 |
|
phosphoric monoester hydrolases - chemistry - genetics - metabolism |
2 |
|
promoter |
2 |
|
protein function |
2 |
|
proteins - genetics |
2 |
|
proto-oncogene proteins c-met - metabolism |
2 |
|
rats |
2 |
|
receptor cross-talk - drug effects - physiology |
2 |
|
reverse transcriptase polymerase chain reaction |
2 |
|
sequence alignment |
2 |
|
signal transduction - drug effects - physiology |
2 |
|
sodium-hydrogen exchanger |
2 |
|
stemness |
2 |
|
transcriptional regulation |
2 |
|
tumor suppressor proteins - chemistry - genetics - metabolism |
2 |
|
tumour microenvironment |
2 |
|
adenomatous polyposis coli protein - analysis |
1 |
|
alkaline phosphatase reporter assay |
1 |
|
alternative splicing |
1 |
|
beta catenin |
1 |
|
breast - chemistry |
1 |
|
breast cancer |
1 |
|
breast carcinoma |
1 |
|
breast neoplasms - chemistry - pathology |
1 |
|
camp responsive element binding protein |
1 |
|
cancer |
1 |
|
cancer-associated fibroblasts |
1 |
|
carcinoma, ductal, breast - chemistry - pathology |
1 |
|
cell line, transformed |
1 |
|
cell membrane - chemistry |
1 |
|
cell transformation, neoplastic - genetics |
1 |
|
cell-free nucleic acids |
1 |
|
cho cells |
1 |
|
chromosome mapping - methods - statistics & numerical data |
1 |
|
circ_abcb10 |
1 |
|
circrna |
1 |
|
circular rnas |
1 |
|
circulating tumour cells |
1 |
|
conserved sequence - genetics |
1 |
|
creb |
1 |
|
cricetinae |
1 |
|
crosstalk |
1 |
|
cyclic amp response element-binding protein - genetics - physiology |
1 |
|
cyclic amp-dependent protein kinases - physiology |
1 |
|
cyclin d1 - analysis |
1 |
|
cyr61 |
1 |
|
cytoskeletal protein |
1 |
|
cytoskeletal proteins - analysis |
1 |
|
dgcr5 |
1 |
|
diagnostic marker |
1 |
|
dlc1 |
1 |
|
dna |
1 |
|
dna primers - genetics |
1 |
|
early diagnosis |
1 |
|
electrophoretic mobility shift assay |
1 |
|
energy stress |
1 |
|
environmental stress |
1 |
|
exosomes |
1 |
|
extracellular vesicle |
1 |
|
ferroptosis |
1 |
|
fibroblasts - metabolism |
1 |
|
fluorescent primer |
1 |
|
follistatin-related proteins |
1 |
|
frizzled-related protein |
1 |
|
frizzled-related protein β-catenin |
1 |
|
gene expression regulation - genetics |
1 |
|
genes, myc - genetics |
1 |
|
genes, p53 - genetics |
1 |
|
genes, ras - genetics |
1 |
|
genes, reporter - genetics |
1 |
|
genescan® |
1 |
|
genetic techniques - statistics & numerical data |
1 |
|
genetic variation |
1 |
|
glycoproteins - analysis - metabolism |
1 |
|
immunohistochemistry |
1 |
|
in situ hybridization |
1 |
|
interacting partner |
1 |
|
liquid biopsies |
1 |
|
lncrna |
1 |
|
lymph node metastases |
1 |
|
macromolecular substances |
1 |
|
metabolic reprogramming |
1 |
|
metastasis suppressor |
1 |
|
microenvironment |
1 |
|
microvascular invasion |
1 |
|
molecular mechanism |
1 |
|
molecular targets |
1 |
|
mrna differential display |
1 |
|
myc and cyclin d1 |
1 |
|
myosin heavy chains - genetics |
1 |
|
neuron-restrictive silencer element |
1 |
|
nm23 |
1 |
|
nme |
1 |
|
nmmhc |
1 |
|
non-coding rnas |
1 |
|
nonmuscle myosin heavy chain-b |
1 |
|
nonmuscle myosin type iib |
1 |
|
oral tongue squamous cell carcinoma |
1 |
|
p53 tumor suppressor gene |
1 |
|
point mutation |
1 |
|
primer extension |
1 |
|
progress |
1 |
|
proliferation |
1 |
|
promoter regions, genetic |
1 |
|
promoter regions, genetic - genetics |
1 |
|
proto-oncogene proteins - analysis - metabolism |
1 |
|
proto-oncogene proteins c-myc - analysis |
1 |
|
race |
1 |
|
random amplified polymorphic dna technique - methods - statistics & numerical data |
1 |
|
rat 6 |
1 |
|
rat 6 fibroblast |
1 |
|
rat frizzled related protein (rfrp) |
1 |
|
regulation |
1 |
|
regulation mechanism |
1 |
|
response elements - genetics |
1 |
|
ribonucleases |
1 |
|
rna, messenger - analysis - genetics |
1 |
|
rna, messenger - genetics |
1 |
|
sequence analysis |
1 |
|
small extracellular vesicle biomarkers |
1 |
|
small extracellular vesicle isolation |
1 |
|
small extracellular vesicle-based diagnosis |
1 |
|
sorafenib |
1 |
|
sponge |
1 |
|
targeting |
1 |
|
trans-activators |
1 |
|
transcription initiation site |
1 |
|
transcription, genetic - genetics |
1 |
|
transcriptional activation |
1 |
|
transcriptional factor |
1 |
|
transformation |
1 |
|
treatment response monitoring |
1 |
|
tumor escape |
1 |
|
tumor immune environment |
1 |
|
tumor suppression |
1 |
|
tumor suppressor gene |
1 |
|
tumor suppressor protein p53 - genetics |
1 |
|
tumor suppressor protein p53 - genetics - metabolism |
1 |
|
wnt |
1 |
|
wnt proteins |
1 |
|
wnt1 protein |
1 |
|
zebrafish proteins |
1 |
